NCT00142246View on ClinicalTrials.gov

Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.

PHASE3CompletedINTERVENTIONAL
Enrollment

6,758

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Malaria, Falciparum
Interventions
DRUG

Intermittent preventive treatment (SP and amodiaquine)

Oral medication. SP: single dose given over one day; amodiaquine: 3 daily doses over 3 days. Dosage has given according to age.

OTHER

Placebo

Three doses given over three days (Day 1: placebo SP + placebo AQ; Days 2 and 3: placebo AQ). Dosage given according to age

Trial Locations (1)

Unknown

Primary schools within Bondo district / Bondo District Hospital, Bondo

All Listed Sponsors
collaborator

University of Nairobi

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00142246 - Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education. | Biotech Hunter | Biotech Hunter